WELL Health Technologies Corp.
WHTCF
$3.14
-$0.06-1.88%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.49% | 32.91% | 22.59% | 15.44% | 16.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.49% | 32.91% | 22.59% | 15.44% | 16.76% |
| Cost of Revenue | 37.82% | 32.06% | 27.89% | 29.92% | 35.78% |
| Gross Profit | 67.36% | 34.10% | 15.57% | -1.68% | -3.86% |
| SG&A Expenses | 32.23% | 27.54% | 20.82% | 12.64% | 13.96% |
| Depreciation & Amortization | 27.52% | 32.25% | 22.55% | 16.08% | 17.09% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.15% | 30.56% | 25.07% | 22.63% | 26.10% |
| Operating Income | 414.92% | 224.69% | -88.00% | -173.95% | -183.52% |
| Income Before Tax | -26.40% | -139.01% | -185.24% | -204.81% | -53.45% |
| Income Tax Expenses | 105.12% | 158.11% | 20.45% | -8,187.86% | -788.76% |
| Earnings from Continuing Operations | -80.55% | -142.52% | -176.29% | -160.19% | 75.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -452.26% | 157.86% | 90.63% | 110.16% | 119.35% |
| Net Income | -117.88% | -138.89% | -185.10% | -191.24% | 17,519.93% |
| EBIT | 414.92% | 224.69% | -88.00% | -173.95% | -183.52% |
| EBITDA | 509.04% | 60.50% | -10.01% | -58.01% | -68.73% |
| EPS Basic | -118.50% | -135.61% | -183.14% | -180.39% | 3,862.96% |
| Normalized Basic EPS | 113.88% | 78.00% | -1.99% | -81.56% | -133.04% |
| EPS Diluted | -124.27% | -140.26% | -185.95% | -202.21% | 1,451.47% |
| Normalized Diluted EPS | 113.57% | 76.87% | -4.52% | -82.58% | -129.41% |
| Average Basic Shares Outstanding | 5.33% | 0.27% | 0.88% | 1.26% | 1.66% |
| Average Diluted Shares Outstanding | 4.08% | -0.86% | -0.64% | 1.14% | 3.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |